QX1206

· 1Globe Health Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QX1206, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of QX1206 in T2DM Patients With NAFLD [Phase 1]